JeanChristophe Marcoux - Genfit Chief Officer
| GNFT Stock | EUR 3.91 0.02 0.51% |
Insider
JeanChristophe Marcoux is Chief Officer of Genfit
| Age | 46 |
| Phone | (33) 3 20 16 40 01 |
| Web | www.genfit.com |
Genfit Management Efficiency
The company has return on total asset (ROA) of 0.1532 % which means that it generated a profit of $0.1532 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6745 %, meaning that it generated $0.6745 on every $100 dollars invested by stockholders. Genfit's management efficiency ratios could be used to measure how well Genfit manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michele Robertson | DBV Technologies SA | N/A | |
| Adam Slatter | DBV Technologies SA | 51 | |
| Pascal Wotling | DBV Technologies SA | N/A | |
| Kathryn McNeil | Nanobiotix SA | 48 | |
| Laurent Levy | Nanobiotix SA | 50 | |
| DVM MBA | Innate Pharma | 58 | |
| Pr Prasad | Nanobiotix SA | 78 | |
| Frederic MBA | Innate Pharma | 48 | |
| AnneJuliette MA | Nanobiotix SA | 49 | |
| Joseph Becker | DBV Technologies SA | N/A | |
| Franois Romagn | Innate Pharma | 59 | |
| Grgory Meiffren | Adocia | N/A | |
| Grard Soula | Adocia | 78 | |
| Pascalyne Wilson | Cellectis | N/A | |
| Caroline Daniere | DBV Technologies SA | 48 | |
| Jean Epinat | Cellectis | N/A | |
| Brandon Owens | Nanobiotix SA | N/A | |
| Anne Pollak | DBV Technologies SA | N/A | |
| Mondher MD | Innate Pharma | 65 | |
| Jean Fourni | Innate Pharma | N/A | |
| MSc MSc | Cellectis | 54 | |
Management Performance
| Return On Equity | 0.67 | |||
| Return On Asset | 0.15 |
Genfit Leadership Team
Elected by the shareholders, the Genfit's board of directors comprises two types of representatives: Genfit inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genfit. The board's role is to monitor Genfit's management team and ensure that shareholders' interests are well served. Genfit's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genfit's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stefanie Magner, Chief Affairs | ||
| Pascal Caisey, Chief Officer | ||
| Dean Hum, COO, Chief Scientific Officer, Member of the Management Board | ||
| Thomas Baetz, Chief Officer | ||
| Pr Staels, CoFounder Board | ||
| JeanChristophe Marcoux, Chief Officer | ||
| Pascal Prigent, Chief Officer | ||
| Laurent Lannoo, Corp Affairs | ||
| Emilie Desodt, VicePres HR | ||
| JeanFrancois Mouney, Chairman of the Management Board, CEO |
Genfit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genfit a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.67 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.51 % | |||
| Operating Margin | 0.48 % | |||
| Current Valuation | 30.62 M | |||
| Shares Outstanding | 49.82 M | |||
| Shares Owned By Insiders | 13.22 % | |||
| Shares Owned By Institutions | 2.47 % | |||
| Price To Earning | (18.01) X | |||
| Price To Book | 1.51 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Genfit Stock
When determining whether Genfit is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Genfit Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Genfit Stock. Highlighted below are key reports to facilitate an investment decision about Genfit Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genfit. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Genfit Stock refer to our How to Trade Genfit Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.